Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
GLP-1 Drug Semaglutide Substantially Reduced Heavy Alcohol Consumption and Weight in Patients with Alcohol Use Disorder and Obesity Researchers have reported positive results in the first clinical trial testing the diabetes and weight-loss medicine semaglutide (Ozempic, Wegovy) in treatment-seeking patents with alcohol use disorder (AUD) who were also obese
One of the most common things patients report: My brain finally feels quiet around food. GLP-1s may help reduce obsessive thoughts about eating, snacking, binge behaviors, and constant cravings
2 Theanine may support gut health by decreasing intestinal pressure, reducing inflammation, and providing antioxidant activity2
This treatment is also suitable for individuals who have tried weight loss through lifestyle changes alone and want to try a medication-assisted approach to achieve sustained weight management
US$ 21.75
US$ 23.92
US$ 24.90
US$ 28.11
US$ 29.23
